Dr. Deborah O. Setter, MD, PHD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2019)
- Years since graduation
- 7
- In the NPI registry since
- 2019
- Medicare patients seen, 2024
- 41
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Medical school: Indiana University School of Medicine
- 2019Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
MN license 67800
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Olmsted Medical Center Rochester, MN
Medical groups
- Olmsted Medical Center (336 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 41
- Services billed
- 96
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 41 | 14 |
| New patient office or other outpatient visit, 60-74 minutes | 19 | 19 |
| Established patient office or other outpatient visit, 40-54 minutes | 14 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 8 companies reported 12 payments worth $311 in total to this clinician.
| Biogen, Inc. | $138 |
|---|---|
| Teva Pharmaceuticals USA, Inc. | $57.39 |
| Genentech USA, Inc. | $28.17 |
| Neurocrine Biosciences, Inc. | $20.73 |
| Lundbeck LLC | $18.31 |
| Eisai Inc. | $17.43 |
| Novartis Pharmaceuticals Corporation | $16.38 |
| Lilly USA, LLC | $15.02 |
| Food and Beverage | $248 |
|---|---|
| Education | $63.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Biogen, Inc. Jul 23, 2025 | Education in-kind | $63.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.